{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:30:15Z","timestamp":1760711415074,"version":"3.40.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clinbiochem.2024.110780","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:37:36Z","timestamp":1718779056000},"page":"110780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Investigating angiogenin\/ribonuclease 5 as a diagnostic biomarker for bladder cancer: In-depth analysis from a systematic review and meta-analysis"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4928-254X","authenticated-orcid":false,"given":"Amir Hossein","family":"Aalami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Abdeahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnoosh","family":"Aalami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2024.110780_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119681","article-title":"Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA","volume":"1871","author":"Zhu","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0010","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/ijms25042178","article-title":"The role of miRNAs to detect progression, stratify, and predict relevant clinical outcomes in bladder cancer","volume":"25","author":"Torres-Bustamante","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102294","article-title":"Global changes in bladder cancer mortality in the elderly","volume":"82","author":"Tempo","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0035","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10147-022-02216-7","article-title":"Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis","volume":"27","author":"Aalami","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/cancers16040758","article-title":"Diagnostic value of urine cytology in pharmacologically forced diuresis for upper tract urothelial carcinoma diagnosis and follow-up","volume":"16","author":"Giudici","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104236","article-title":"Predictors of response to neoadjuvant therapy in urothelial cancer","volume":"194","author":"Tripathi","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0050","series-title":"Ureteral Tumors. The Ureter: A Comprehensive Review","first-page":"369","author":"Aufderklamm","year":"2024"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0055","article-title":"Off the fog to find the optimal choice: Research advances in biomarkers for early diagnosis and recurrence monitoring of bladder cancer","author":"Zhao","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/cancers15030709","article-title":"Diagnostic performance of biomarkers for bladder cancer detection suitable for community and primary care settings: A systematic review and meta-analysis","volume":"15","author":"Papavasiliou","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116312","article-title":"Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer","volume":"173","author":"Fan","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12864-023-09888-z","article-title":"Transcriptomic analysis of glucosidase II beta subunit (GluII\u00df) knockout A549 cells reveals its roles in regulation of cell adhesion molecules (CAMs) and anti-tumor immunity","volume":"25","author":"Khaodee","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/nano10050879","article-title":"XPS modeling of immobilized recombinant angiogenin and apoliprotein A1 on biodegradable nanofibers","volume":"10","author":"Manakhov","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5557309","article-title":"Urinary angiogenin as a marker for bladder cancer: a meta-analysis","volume":"2021","author":"Aalami","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0085","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1745-7270.2008.00442.x","article-title":"Mechanisms of action of angiogenin","volume":"40","author":"Gao","year":"2008","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.onc.1208223","article-title":"Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis","volume":"24","author":"Kishimoto","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0100","article-title":"Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response","volume":"10","author":"Wang","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24556","article-title":"Tailoring the stress response of human skin cells by substantially limiting the nuclear localization of angiogenin","volume":"10","author":"Culurciello","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/path.6244","article-title":"Neural stem cell homeostasis is affected in cortical organoids carrying a mutation in Angiogenin","author":"Ferguson","year":"2024","journal-title":"J. Pathol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/acs.jafc.3c05789","article-title":"Generation of porcine angiogenin 4-expressing pichia pastoris and its protection against intestinal inflammatory injury","volume":"72","author":"Xu","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/nano11010201","article-title":"Gold nanoparticles functionalized with angiogenin for wound care application","volume":"11","author":"Cucci","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0125","doi-asserted-by":"crossref","first-page":"10704","DOI":"10.3390\/ijms221910704","article-title":"Angiogenin and copper crossing in wound healing","volume":"22","author":"Cucci","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0130","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.omtn.2022.01.017","article-title":"Angiogenin promotes angiogenesis via the endonucleolytic decay of miR-141 in colorectal cancer","volume":"27","author":"Weng","year":"2022","journal-title":"Mol. Ther.-Nucleic Acids"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/22201173.2004.10872376","article-title":"Evaluating diagnostic tests","volume":"10","author":"Coetzee","year":"2004","journal-title":"South. Afr. J. Anaesth. Analg."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijid.2021.04.004","article-title":"Managing the risks of making the wrong diagnosis: First, do no harm","volume":"106","author":"Olliaro","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2023.104426","article-title":"A statistical comparison between Matthews correlation coefficient (MCC), prevalence threshold, and Fowlkes-Mallows index","volume":"144","author":"Chicco","year":"2023","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0155","article-title":"Diagnostic test accuracy: application and practice using R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0160","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.clinbiochem.2004.05.027","article-title":"Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma","volume":"37","author":"Eissa","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0165","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.juro.2008.10.102","article-title":"A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot","volume":"181","author":"Eissa","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-0783-2","article-title":"A multiplex immunoassay for the non-invasive detection of bladder cancer","volume":"14","author":"Shimizu","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0175","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-014-9765-y","article-title":"Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer","volume":"20","author":"Shabayek","year":"2014","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0180","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-14-0029","article-title":"External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort","volume":"23","author":"Chen","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2012.01.016","article-title":"Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection","volume":"79","author":"Urquidi","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0190","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1055-9965.EPI-14-0035","article-title":"Urinary protein biomarker panel for the detection of recurrent bladder cancer","volume":"23","author":"Rosser","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/diagnostics10010014","article-title":"Prognostic significance of lymphocyte infiltration and a stromal immunostaining of a bladder cancer associated diagnostic panel in urothelial carcinoma","volume":"10","author":"Furuya","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0200","doi-asserted-by":"crossref","unstructured":"Zhao Y, Wang K, Zhao C, et al. (2024) The function of tRNA-derived small RNAs in cardiovascular diseases. Molecular Therapy-Nucleic Acids.","DOI":"10.1016\/j.omtn.2024.102114"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67929-z","article-title":"Circulating proteomic signature for detection of biomarkers in bladder cancer patients","volume":"10","author":"Nedjadi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0210","first-page":"1","article-title":"MicroRNAs: key players in bladder cancer","author":"Li","year":"2019","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-018-2503-4","article-title":"Molecular markers in bladder cancer","volume":"37","author":"Soria","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0220","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fonc.2018.00362","article-title":"Urinary markers in bladder cancer: an update","volume":"8","author":"Santoni","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0225","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1984718","article-title":"The potential of angiogenin as a serum biomarker for diseases: systematic review and meta-analysis","author":"Yu","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/CEJ.0b013e3283647453","article-title":"Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening?","volume":"23","author":"Pina","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0235","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.2174\/0929867330666230622114235","article-title":"Detection of circulating cell-free DNA to diagnose hepatocellular carcinoma in Chinese population: A systematic review and meta-analysis","volume":"31","author":"Aalami","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0240","first-page":"1","article-title":"Advancing gastrointestinal cancer diagnostics: A systematic review and meta-analysis of circulating microRNA-1246 as a non-invasive biomarker","author":"Aalami","year":"2024","journal-title":"Biomarkers"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0245","doi-asserted-by":"crossref","unstructured":"A.H. Aalami, H. Abdeahad, F. Aalami, A. Amirabadi, Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer. Urologic Oncology: Seminars and Original Investigations. Elsevier, pp 52. e51-52. e10.","DOI":"10.1016\/j.urolonc.2022.09.022"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0250","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.2174\/0929867330666221121155905","article-title":"Gastric cancer and circulating microRNAs: An updated systematic review and diagnostic meta-analysis","volume":"30","author":"Aalami","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0255","doi-asserted-by":"crossref","DOI":"10.2174\/0929867330666230509110111","article-title":"Blood-based microRNAs as potential diagnostic biomarkers for melanoma: A meta-analysis","author":"Aalami","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0260","unstructured":"K. Ng, A. Stenzl, A. Sharma, N. Vasdev, Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urologic Oncology: Seminars and Original Investigations. Elsevier."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0265","first-page":"2631","article-title":"Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer","volume":"133","author":"Mengual","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0270","doi-asserted-by":"crossref","first-page":"e100793","DOI":"10.1371\/journal.pone.0100793","article-title":"Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0275","doi-asserted-by":"crossref","unstructured":"K. Ng, A. Stenzl, A. Sharma, N. Vasdev, Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urologic Oncology: Seminars and Original Investigations. Elsevier, pp 41-51.","DOI":"10.1016\/j.urolonc.2020.08.016"},{"key":"10.1016\/j.clinbiochem.2024.110780_b0280","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.21037\/tcr-20-1824","article-title":"The diagnostic and prognostic value of nuclear matrix protein 22 in bladder cancer","volume":"9","author":"Tang","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0285","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.eururo.2005.09.002","article-title":"Urinary NMP22\u00ae BladderChek\u00ae test in the diagnosis of superficial bladder cancer","volume":"48","author":"Moonen","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0290","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/ajco.13024","article-title":"Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis","volume":"15","author":"Mi","year":"2019","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110780_b0295","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0009-9120(02)00321-1","article-title":"Diagnostic value of cytokeratin-18 as a tumor marker in bladder cancer","volume":"35","author":"\u015eekero\u011flu","year":"2002","journal-title":"Clin. Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:02:17Z","timestamp":1732255337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":59,"alternative-id":["S0009912024000742"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110780","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating angiogenin\/ribonuclease 5 as a diagnostic biomarker for bladder cancer: In-depth analysis from a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110780"}}